Pembrolizumab and Palliative Radiotherapy in Lung

NCT02587455 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Thoracic Tumours

Interventions

DRUG: Pembrolizumab
RADIATION: Radiotherapy

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]